313 related articles for article (PubMed ID: 1336346)
1. Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus.
Earnshaw DL; Bacon TH; Darlison SJ; Edmonds K; Perkins RM; Vere Hodge RA
Antimicrob Agents Chemother; 1992 Dec; 36(12):2747-57. PubMed ID: 1336346
[TBL] [Abstract][Full Text] [Related]
2. Mode of action of 9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine (BRL 39123) against herpes simplex virus in MRC-5 cells.
Hodge RA; Perkins RM
Antimicrob Agents Chemother; 1989 Feb; 33(2):223-9. PubMed ID: 2541655
[TBL] [Abstract][Full Text] [Related]
3. Mode of action of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl) cycloprop-1'-yl]methyl]guanine (A-5021) against herpes simplex virus type 1 and type 2 and varicella-zoster virus.
Ono N; Iwayama S; Suzuki K; Sekiyama T; Nakazawa H; Tsuji T; Okunishi M; Daikoku T; Nishiyama Y
Antimicrob Agents Chemother; 1998 Aug; 42(8):2095-102. PubMed ID: 9687413
[TBL] [Abstract][Full Text] [Related]
4. Mode of action of (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine against herpesviruses.
Lowe DM; Alderton WK; Ellis MR; Parmar V; Miller WH; Roberts GB; Fyfe JA; Gaillard R; Ertl P; Snowden W
Antimicrob Agents Chemother; 1995 Aug; 39(8):1802-8. PubMed ID: 7486922
[TBL] [Abstract][Full Text] [Related]
5. Comparison of a DNA probe assay with the plaque reduction assay for measuring the sensitivity of herpes simplex virus and varicella-zoster virus to penciclovir and acyclovir.
Standring-Cox R; Bacon TH; Howard BA
J Virol Methods; 1996 Jan; 56(1):3-11. PubMed ID: 8690764
[TBL] [Abstract][Full Text] [Related]
6. Broad-spectrum antiviral activity of the acyclic guanosine phosphonate (R,S)-HPMPG.
Terry BJ; Mazina KE; Tuomari AV; Haffey ML; Hagen M; Feldman A; Slusarchyk WA; Young MG; Zahler R; Field AK
Antiviral Res; 1988 Dec; 10(4-5):235-51. PubMed ID: 2852486
[TBL] [Abstract][Full Text] [Related]
7. In vitro activities of penciclovir and acyclovir against herpes simplex virus types 1 and 2.
Weinberg A; Bate BJ; Masters HB; Schneider SA; Clark JC; Wren CG; Allaman JA; Levin MJ
Antimicrob Agents Chemother; 1992 Sep; 36(9):2037-8. PubMed ID: 1329640
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of purified human and herpes simplex virus-induced DNA polymerases by 9-(2-hydroxyethoxymethyl)guanine triphosphate. Effects on primer-template function.
Derse D; Cheng YC; Furman PA; St Clair MH; Elion GB
J Biol Chem; 1981 Nov; 256(22):11447-51. PubMed ID: 6271750
[TBL] [Abstract][Full Text] [Related]
9. Viral ribonucleotide reductase attenuates the anti-herpes activity of acyclovir in contrast to amenamevir.
Shiraki K; Tan L; Daikoku T; Takemoto M; Sato N; Yoshida Y
Antiviral Res; 2020 Aug; 180():104829. PubMed ID: 32569704
[TBL] [Abstract][Full Text] [Related]
10. Metabolism and mode of action of (R)-9-(3,4-dihydroxybutyl)guanine in herpes simplex virus-infected vero cells.
Stenberg K; Larsson A; Datema R
J Biol Chem; 1986 Feb; 261(5):2134-9. PubMed ID: 2418021
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of varicella-zoster virus-induced DNA polymerase by a new guanosine analog, 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine triphosphate.
Abele G; Eriksson B; Harmenberg J; Wahren B
Antimicrob Agents Chemother; 1988 Aug; 32(8):1137-42. PubMed ID: 2847643
[TBL] [Abstract][Full Text] [Related]
12. Activity of penciclovir in antiviral assays against herpes simplex virus.
Bacon TH; Howard BA; Spender LC; Boyd MR
J Antimicrob Chemother; 1996 Feb; 37(2):303-13. PubMed ID: 8707740
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory action of acyclovir (ACV) and penciclovir (PCV) on plaque formation and partial cross-resistance of ACV-resistant varicella-zoster virus to PCV.
Hasegawa T; Kurokawa M; Yukawa TA; Horii M; Shiraki K
Antiviral Res; 1995 Jun; 27(3):271-9. PubMed ID: 8540749
[TBL] [Abstract][Full Text] [Related]
14. The biochemistry and mechanism of action of acyclovir.
Elion GB
J Antimicrob Chemother; 1983 Sep; 12 Suppl B():9-17. PubMed ID: 6313600
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of DNA synthesis in varicella-zoster virus-infected cells by BV-araU.
Machida H; Watanabe Y
Microbiol Immunol; 1991; 35(2):139-45. PubMed ID: 1653394
[TBL] [Abstract][Full Text] [Related]
16. Mode of action of acyclovir triphosphate on herpesviral and cellular DNA polymerases.
Allaudeen HS; Descamps J; Sehgal RK
Antiviral Res; 1982 Aug; 2(3):123-33. PubMed ID: 6291456
[TBL] [Abstract][Full Text] [Related]
17. Intracellular metabolism and enzymatic phosphorylation of 9-(1,3-dihydroxy-2-propoxymethyl)guanine and acyclovir in herpes simplex virus-infected and uninfected cells.
Smee DF; Boehme R; Chernow M; Binko BP; Matthews TR
Biochem Pharmacol; 1985 Apr; 34(7):1049-56. PubMed ID: 3872662
[TBL] [Abstract][Full Text] [Related]
18. The pharmacological profile of famciclovir.
Crumpacker C
Semin Dermatol; 1996 Jun; 15(2 Suppl 1):14-26. PubMed ID: 8840412
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of action and selectivity of acyclovir.
Elion GB
Am J Med; 1982 Jul; 73(1A):7-13. PubMed ID: 6285736
[TBL] [Abstract][Full Text] [Related]
20. Emergence of resistance to acyclovir and penciclovir in varicella-zoster virus and genetic analysis of acyclovir-resistant variants.
Ida M; Kageyama S; Sato H; Kamiyama T; Yamamura J; Kurokawa M; Morohashi M; Shiraki K
Antiviral Res; 1999 Jan; 40(3):155-66. PubMed ID: 10027650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
